Faculty

Megan S Lim, MD, PhD

faculty photo
Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Department: Pathology and Laboratory Medicine
Graduate Group Affiliations

Contact information
Department of Pathology and Laboratory Medicine
Stellar Chance Office Suite 609C
422 Curie Blvd.
Philadelphia, PA 19104
Office: 215-898-4719
Fax: 215-898-9969
Education:
BS (Cell and Microbiology)
University of Calgary, 1983.
MS (Biochemistry, Cell Regulation Group, Department of Medical Biochemistry, Faculty of Medicine)
University of Calgary, 1985.
MD (Medicine)
University of Calgary, 1988.
PhD (Molecular Oncology)
University of Calgary joint with National Cancer Institute, National Institute of Health, 1999.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Chunn LM, Nefcy DC, Ritter RW, Tarpey RP, Chuahan G, Lim MS, Elenitoba-Johnson KSJ, Schwartz SA and Kiel MJ.: Mastermind: A comprehensive genomic association search engine for empirical evidence curation and genetic variant interpretation. Front Genet. Emmanouil Dermitzakis, Field Chief Editors (eds.). Frontiers Media SA, 11, November 2020.

Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, Srkalovic G, Mukherjee S, Leitch H, Jayanthan R, Ferrero S, Sato Y, Schey S, Dispenzieri A, Oksenhendler E, Zinzani PL, Lechowicz MJ, Hoffman C, Pemmaraju N, Bagg A, Fossa A, Lim MS, van Rhee F.: Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. Am J Hematol. Wiley Periodicals, September 2020.

Hayashi RJ, Winter SS, Dunsmore KP, Devidas M, Chen Z, Wood BL, Hermiston M, Teachey DT, Perkins SL, Miles RR, Raetz EA, Loh ML, Winick NJ, Carroll WL, Hunger SP, Lim MS, Gross TG, Bollard CM: Successful Disease Control Without Cranial Radiation in Newly Diagnosed T Lymphoblastic Lymphoma (T-LL): Results from Children’s Oncology Group AALL0434. J Clin Oncol. Jonathan W. Friedberg, MD, MMSc (eds.). ASCO Publications, June 2020 Notes: Published online ahead of print.

Koh J, Jang I, Choi S, Kim S, Jang I, Ahn HK, Lee C, PaiK JH, Kim CW, Lim MS, Kim K*, Jeon YK*: Discovery of novel recurrent mutations and clinically meaningful subgroups in nodal marginal zone lymphoma. Cancers. MDPI, 12(6): 1669, June 2020.

Svoboda J, Landsburg DJ, Dwivedy Nasta S, Blair SM, Nagle SJ, Barta SK, Khan N, Filicko-O’Hare J, Gaballa S, Strelec L, Chong E, Mitnick S, Waite TS, King C, Ballard H, Youndman M, Gerson J, Plastaras JP, Maity A, Bogusz AM, Hung SS, Nakamura H, Nejati R, Steidl C, Lim MS, Ruella M, Schuster SJ: Brentuximab Vedotin with R-CHP chemotherapy as frontline treatment for patients with CD30+ PMBCL, DLBCL, and GZL. Haematologica. Jan Cools (eds.). Ferrata Storti Foundation (Italy), May 2020 Notes: Published online MAY 2020.

Wierda WG, Byrd JC, Abramson JS, Bilgrami SF, Bociek G, Brander D, Brown J, Chanan-Khan AA, Chavez JC, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Lim MS, Ma S, Malek S, Mato A, Mosse C, Shadman M, Siddiqi T, Stephens D, Sundaram S, Wagner N, Dwyer M, Sundar H. : Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. Harold J. Burstein (eds.). Harborside Press, 18(2): 185-217, February 2020.

Levantaki V, Bhattacharyya S, Lim MS.: Pathology and genetics of anaplastic large cell lymphoma. Semin in Diag Pathol. Justin A. Bishop, MD (eds.). Elsevier, 37: 57-71, January 2020 Notes: Epub 2019 Dec 18.

Rajan SS, Amin AD, Li L, Rolland DCM, Li H, Kwon D, Kweh MF, Arumoy A, Yan A, Basrur V, Elenitoba-Johnson KSJ, Chen X, Puvvada SD, Lussier YA, Bilbao D, Lim MS, Schatz JH: The mechanism of cancer drug addiction in ALK-Positive T-cell lymphoma. Oncogene. Dr. George Miller (eds.). Nature Publishing Group, Page: Epub ahead of print, December 2019.

Murga-Zamalloa C, Rolland DSC, Polk A, Wolfe A, Dewar H, Chowdury P, Önder Ö, Dewar R, Brown N, Bailey N, Inamdar K, Lim MS, Elenitoba-Johnson KSJ, and Ryan Wilcox: Colony-stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-cell Lymphoma Viability. Clinical Cancer Research. Keith T. Flaherty (eds.). American Association for Cancer Research, Page: 1486, October 2019 Notes: Epub ahead of print.

Lim MS, Bailey NG, King RL, Piris M. : Molecular genetics in the diagnosis and biology of lymphoid neoplasms: 2017 Society of Hematopathology/European Association of Haematopathology Workshop Report. Am J Clin Pathol. Steven H. Kroft, MD, MASCP (eds.). Oxford Academic, 152(3): 277-301, July 2019 Notes: Epub ahead of print.

back to top
Last updated: 01/20/2021
The Trustees of the University of Pennsylvania